CLINICAL TRIALS PROFILE FOR APRACLONIDINE HYDROCHLORIDE
⮫ Send this page by email
✉ Email this page to a colleague
« Back to Dashboard
All Clinical Trials for APRACLONIDINE HYDROCHLORIDE
Trial ID
Title
Status
Sponsor
Phase
Start Date
Summary
NCT00567411 ↗ Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Unknown status
Walter Reed Army Medical Center
N/A
2006-08-01
The purpose of the study is to compare the safety and efficacy of two drops used to lower eye
pressure when given prior to a glaucoma laser procedure.
NCT05045248 ↗ Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
Completed
American University of Beirut Medical Center
Phase 2
2020-06-01
This study is aimed at assessing the efficacy of Apraclonidine eye drops in the treatment of
ptosis secondary to myasthenia gravis.
NCT05167760 ↗ Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis
Not yet recruiting
University of Alabama at Birmingham
Phase 4
2022-02-01
The purpose of this study is to determine efficacy of apraclonidine for patients with ocular
synkinesis, who are seen in the UAB Facial Nerve Clinic.
>Trial ID
>Title
>Status
>Phase
>Start Date
>Summary
Clinical Trial Conditions for APRACLONIDINE HYDROCHLORIDE
Condition Name
Condition Name for APRACLONIDINE HYDROCHLORIDE
Intervention
Trials
Synkinesis
1
Facial Nerve Palsy
1
Glaucoma
1
Myasthenia Gravis
1
[disabled in preview]
0
Subscribe for full access, or try a Trial
Condition MeSH
Condition MeSH for APRACLONIDINE HYDROCHLORIDE
Intervention
Trials
Ocular Hypertension
1
Synkinesis
1
Glaucoma
1
Facial Paralysis
1
[disabled in preview]
0
Subscribe for full access, or try a Trial
Clinical Trial Locations for APRACLONIDINE HYDROCHLORIDE
Trials by Country
Trials by Country for APRACLONIDINE HYDROCHLORIDE
Location
Trials
United States
2
Lebanon
1
Subscribe for full access, or try a Trial
Trials by US State
Trials by US State for APRACLONIDINE HYDROCHLORIDE
Location
Trials
Alabama
1
District of Columbia
1
Subscribe for full access, or try a Trial
Clinical Trial Progress for APRACLONIDINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Phase for APRACLONIDINE HYDROCHLORIDE
Clinical Trial Phase
Trials
Phase 4
1
Phase 2
1
N/A
1
[disabled in preview]
0
Subscribe for full access, or try a Trial
Clinical Trial Status
Clinical Trial Status for APRACLONIDINE HYDROCHLORIDE
Clinical Trial Phase
Trials
Unknown status
1
Completed
1
Not yet recruiting
1
[disabled in preview]
0
Subscribe for full access, or try a Trial
Clinical Trial Sponsors for APRACLONIDINE HYDROCHLORIDE
Sponsor Name
Sponsor Name for APRACLONIDINE HYDROCHLORIDE
Sponsor
Trials
Walter Reed Army Medical Center
1
American University of Beirut Medical Center
1
University of Alabama at Birmingham
1
[disabled in preview]
0
Subscribe for full access, or try a Trial
Sponsor Type
Sponsor Type for APRACLONIDINE HYDROCHLORIDE
Sponsor
Trials
Other
2
U.S. Fed
1
[disabled in preview]
0
Subscribe for full access, or try a Trial
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
